RCKT peer analysis
Rocket Pharmaceuticals (RCKT) against its competitors: price, today's move, 1-year return and market value side by side.
- RCKT's peers: ANNX (Annexon), AURA (Aura Biosciences), AUTL (Autolus Therapeutics), DBVT (DBV Technologies), DSGN (Design Therapeutics), GALT (Galectin Therapeutics), LBRX (LB Pharmaceuticals), QSI (Quantum-Si).
RCKT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ANNX Annexon | $3.41 | 0.00% | -16.01% | $650.51M |
| AURA Aura Biosciences | $6.77 | -3.01% | 25.37% | $704.58M |
| AUTL Autolus Therapeutics | $0.92 | -6.08% | -27.56% | $245.03M |
| DBVT DBV Technologies | $9.04 | -4.03% | -36.78% | $216.25M |
| DSGN Design Therapeutics | $9.02 | -3.22% | 22.89% | $577.61M |
| GALT Galectin Therapeutics | $2.81 | -5.70% | -51.05% | $283.46M |
| LBRX LB Pharmaceuticals | $38.85 | -2.97% | 144.72% | $1.26B |
| QSI Quantum-Si | $0.93 | -13.09% | -27.35% | $204.34M |
| SLDB Solid Biosciences | $6.25 | -2.95% | 39.51% | $697.57M |
| RCKT Rocket Pharmaceuticals | $2.01 | -4.77% | -30.23% | $224.36M |